The research is described in a paper published online September 18, 2014, in Immunity, a Cell Press journal. Myeloid-derived suppressor cells (MDSCs) are involved in cancer, inflammation and infection. …
source : http://www.sciencedaily.com/releases/2014/03/140307165917.htm
In laboratory studies, researchers found that the pathway, called mammalian target of rapamycin (mTOR), was highly active in pediatric low-grade gliomas, and that mTOR activity could be blocked using an experimental drug, leading to decreased growth of these tumors. "We think mTOR could function as an Achilles heel," says study co-author Eric Raabe, M.D., Ph.D., an assistant professor of pediatrics, oncology and pathology at the Johns Hopkins Kimmel Cancer Center. "It drives cancer growth, but when mTOR is inhibited, the tumor falls apart." The work was described Nov…